Osteoporosis: Use of Nanoparticles for the Treatment of Osteoporosis
N. Vijaya Sree, P. Udayasri, V. Suresh and K. R. S. Sambasiva RaoCentre for Biotechnology, Acharya Nagarjuna University, Guntur - 522 510 India
Abstract: Osteoporosis is a severe disease faced by most people in the world. It has been estimated that a total of 6,43,000 people in Europe are currently suffering from an osteoporosis – related hip fracture & 1.5 million osteoporosis – related fractures, including 7,00,000 vertebral & 2,50,000 hip fractures each year. Although there is no cure for osteoporosis a broad range of therapies have been approved by the Food and Drug Administration for postmenopausal women to prevent or treat osteoporosis by counter medications such as calcium and vitamin D, estrogen therapy, and newer medications such as “Antiresorptive agents”(i.e., Selective Estrogen – receptor modulators) and Anabolic therapy. As drug treatments have benefits as well as possible side effects and risks. In the place of various drug therapies scientists as well as doctors prefer the patients to undergo nanoparticles treatment for osteoporosis. There are several experimental evidences given by researchers for treatment of osteoporosis by nanoparticles. This review summarises about osteoporosis and the use of nanoparticles in treating osteoporosis.
Keywords: Osteoporosis; Post menopause; Drug therapy; Nanoparticles Back to TOC